SKU: TB500-BPC157 | Category: Peptide Blends
Thymosin Beta-4 fragment + BPC-157 | Dual regenerative research blend | ≥99% purity per component
This combination vial contains equimolar amounts of TB-500 (Thymosin Beta-4 active fragment) and BPC-157 (Body Protection Compound 157), two extensively characterized peptides with complementary but mechanistically distinct profiles studied in connective tissue and vascular biology research.
TB-500 (Ac-SDKPDMAEIEKFDKSKLKKTLKSELLEEHKDLVKFAKDDKDPEGKFQGEYEGLVSAELIKHVEPEEGLASPDSPESESPKSTLSAQPSK) modulates G-actin sequestration via the thymosin beta-4 binding domain, influencing cell motility, lamellipodium formation, and endothelial migration in angiogenesis models. BPC-157 (GEPPPGKPADDAGLV) is studied for its interactions with VEGFR2, nitric oxide synthase activation, and fibroblast proliferation in wound-healing and gastrointestinal epithelial repair models.
Combined study of these peptides allows investigation of actin-based and growth-factor-receptor-based pathways within the same experimental system. Each component independently confirmed at ≥99% purity by HPLC. Manufactured in ISO 9001 certified, GMP-compliant facilities. Per-compound COAs available.
Storage: Store lyophilized at -20°C. Reconstituted blend: 4°C, use within 21 days.
⚠ For laboratory research use only. Not for human or animal consumption.





